$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Size and Composition of T-Cell Receptor δ (TCRD) Junctional Sequences Are Not Predictive of the Sensitivity of Clonospecific Oligonucleotides Designed for Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

International journal of hematology, v.77 no.4, 2003년, pp.371 - 375  

Seriu, Taku ,  Stark, Yvonne ,  Erz, Dorothee ,  Bartram, Claus R.

Abstract AI-Helper 아이콘AI-Helper

We characterized 168 junctional regions of T-cell receptor delta (TCRD) rearrangements from 116 children with acute lymphoblastic leukemia (ALL) (101 with precursor B-cell ALL, 15 with T-cell ALL). Application of 101 allele-specific oligonucleotide (ASO) probes representing 85 Vdelta2Ddelta3, 10 Dde...

참고문헌 (16)

  1. N Engl J Med. H Cave 339 591 1998 10.1056/NEJM199808273390904 Cave H, van der Werfften Bosch J, Suciu S, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia.N Engl J Med. 1998;339:591-598. 

  2. Lancet. JJM Dongen van 352 1731 1998 10.1016/S0140-6736(98)04058-6 van Dongen JJM, Seriu T, Panzer-Grümayer ER, et al. Prognostic value on minimal residual disease in acute lymphoblastic leukaemia in childhood.Lancet. 1998;352:1731-1738. 

  3. Blood. MJ Willemse 99 4386 2002 10.1182/blood.V99.12.4386 Willemse MJ, Seriu T, Hettinger K, et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.Blood. 2002;99:4386-4393. 

  4. Leukemia. MJ Pongers-Willemse 13 110 1999 10.1038/sj.leu.2401245 Pongers-Willemse MJ, Seriu T, Stolz F, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets.Leukemia. 1999;13:110-118. 

  5. Leukemia. MJ Pongers-Willemse 12 2006 1998 10.1038/sj.leu.2401246 Pongers-Willemse MJ, Verhagen OJHM, Tibbe GJM, et al. Realtime quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.Leukemia. 1998;12:2006-2014. 

  6. Cancer Res. M Nakao 60 3281 2000 Nakao M, Janssen JWG, Flohr T, Bartram CR. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.Cancer Res. 2000;60:3281-3289. 

  7. Leukemia. C Guidal 16 762 2002 10.1038/sj.leu.2402396 Guidal C, Vilmer E, Grandchamp B, et al. A competitive PCRbased method usingTCRD, TCRG andIGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.Leukemia. 2002;16:762-764. 

  8. Blood. TM Breit 82 3063 1993 10.1182/blood.V82.10.3063.3063 Breit TM, Wolvers-Tettero IL, Beishuizen A, Verhoven MAJ, van Wering ER, van Dongen JJM. Southern blot patterns, frequencies and junctional diversity of T-cell receptor-δ gene rearrangements in acute lymphoblastic leukemia.Blood. 1993;82:3063-3074. 

  9. Leukemia. T Szczepanski 13 196 1999 10.1038/sj.leu.2401277 Szczepanski T, Beishuizen A, Pongers-Willemse MJ, et al. Crosslineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.Leukemia. 1999;13:196-205. 

  10. Leukemia. TM Breit 5 1076 1991 Breit TM, Wolvers-Tettero ILM, Hählen K, van Wering ER, van Dongen JJM. Extensive junctional diversity of γ δ T-cell receptors expressed by T-cell acute lymphoblastic leukemia: implications for the detection of minimal residual disease.Leukemia. 1991;5:1076-1086. 

  11. Med Pediatr Oncol. A Berg van der Does-van den 20 497 1992 10.1002/mpo.2950200603 van der Does-van den Berg A, Bartram CR, Basso G, et al. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” cooperative group.Med Pediatr Oncol. 1992;20:497-505. 

  12. Blood. S Yokota 77 331 1991 10.1182/blood.V77.2.331.331 Yokota S, Hansen-Hagge TE, Ludwig WD, et al. Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients.Blood. 1991;77:331-339. 

  13. Leukemia. T Seriu 9 316 1995 Seriu T, Hansen-Hagge TE, Erz DHR, Bartram CR. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.Leukemia. 1995;9:316-320. 

  14. Leukemia. T Seriu 11 759 1997 10.1038/sj.leu.2400643 Seriu T, Erz D, Stark Y, Bartram CR. T-cell receptor Dδ2Dδ3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.Leukemia. 1997;11:759-761. 

  15. Blood. TE Hansen-Hagge 85 1888 1995 10.1182/blood.V85.7.1888.bloodjournal8571888 Hansen-Hagge TE, Mahotka C, Panzer-Grümayer RE, et al. Alternative splicing restricts translation of rearrangements at the T-cell receptor δ/ α locus.Blood. 1995;85:1888-1896. 

  16. EMBO J. SM Lewis 10 3631 1991 10.1002/j.1460-2075.1991.tb04929.x Lewis SM, Hesse JE. Cutting and closing without recombination in V(D)J joining.EMBO J. 1991;10:3631-3639. 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로